Journal of Appropriate Technology (적정기술학회지)

Academic Society for Appropriate Technology (적정기술학회)
권호 표지
DOI QR코드

DOI QR Code

Development of Portable AIDS Diagnosis Device

휴대용 AIDS 검사기기 개발

  • ;
  • 태건식 (단국대학교 과학기술대학 생명과학부) ;
  • 성연문 (글로리바이오텍)
  • Received : 2021.10.05
  • Accepted : 2021.11.05
  • Published : 2021.11.20
⟨ Previous Next ⟩

Abstract

It is estimated that there are 40 million people with AIDS worldwide, with most cases occurring mainly in developing countries. HIV, the virus that causes AIDS, is infected with CD4+ T cells in the blood and gradually destroys CD4+ T cells for several months to 10 years, thereby lowering the patient's immune function. AIDS patients who have weakened immunity in this way will die from various diseases. The current method for counting the number of CD4+ T cells is usually performed by flow cytometry. The flow cytometry method has the advantage of high accuracy, but it is difficult to use in developing countries because it requires skilled professionals and equipment is expensive. As a result of this study, a device for AIDS screening was developed by capturing leukocytes from a small amount of 5 ㎕ blood through a microfilter and analyzing CD4+ T cells and CD8+ T cells from the captured cells. cheaper and easier to carry and use than current test equipment.

AIDS 환자는 전 세계에 4,000만 명인 것으로 추산되며, 주로 개발도상국에서 대부분의 환자가 발생하고 있다. AIDS의 원인 바이러스인 HIV는 혈중의 CD4+ T 세포에 감염되어 수개월 내지 10년 간의 잠복기간을 거치면서 CD4+ T 세포를 점점 파괴하여 환자의 면역기능을 저하시킨다. 이렇게 면역력이 약화된 AIDS 환자는 다양한 병증에 의해 사망에 이르게 된다. 현재의 CD4+ T 세포 수를 계측하는 방법은 통상 유세포분석(flow cytometry) 방법에 의해 시행되고 있다. 유세포분석 방법은 정확도가 높다는 장점이 있으나 숙련된 전문 인력이 필요하고 장비가 고가이기때문에 개발도상국에서는 이용하기 어렵다. 본 연구결과로 마이크로 여과기를 통해 소량인 5 ㎕ 혈액으로부터 백혈구를 포획하고 포획된 세포에서 CD4+ T 세포 및 CD8+ T 세포를 분석하여 AIDS를 검사하는 장비를 개발하였다. 현재의 검사 장비보다 저렴하고 고도의 기술이 필요하지 않으며 휴대가 간편한 획기적인 AIDS 검사 장비임을 시사한다.

Keywords

Acknowledgement

본 연구는 2017년 중소기업청 산학연 산학협력연구개발 사업단의 지원을 받았습니다(과제번호 S2501680).

References

  1. Antinori, A. (2011) Late presentation of HIV infection: a consensus definition, HIV Medicine, 12(1), pp. 61-64. https://doi.org/10.1111/j.1468-1293.2010.00857.x
  2. de Wolf. (1988) Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men, The Journal of Infectious Diseases, 158(3), pp. 615-622. https://doi.org/10.1093/infdis/158.3.615
  3. Geneva. (2016) World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach.
  4. Phillips, A. N. (2001) HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA. 286(20), pp. 2560-2567. https://doi.org/10.1001/jama.286.20.2560
  5. Phillips, A. N. (2003) When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies, AIDS, 17(13), pp. 1863-1869. https://doi.org/10.1097/00002030-200309050-00004
  6. Phillips, A. N. (2006) The CD4 lymphocyte count and risk of clinical progression, Current Opinion in HIV and AIDS, 1(1), pp. 43-49. https://doi.org/10.1097/01.COH.0000194106.12816.b1
  7. Sauter, R. (2016) CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART, Medicine, 95(42), e5094. https://doi.org/10.1097/md.0000000000005094